Verifying access...
Entry #32
AES Student Submission form
Submitted: 2025-04-29 18:28:48
Form Fields
Duplicate
Admin Only
ID: 39
Faculty and/or Staff Mentor(s)
- All student submissions for presentations at AES must have the approval of a WOU faculty or staff mentor. To learn more about this requirement please visit http://wou.edu/pure/academicexcellenceshowcase/students/. The identified and approving mentor(s) will be automatically notified upon completion of this form.
- If you do not have a mentor's approval, please discuss your presentation ideas and proposal abstract with a faculty or staff member and ask them for their approval and sponsorship before completing this form.
- You must have approval BEFORE submitting or your presentation may not be included in AES.
Mentor Email
ID: 30
Mentor Name
ID: 29
First: Patricia
Last: Flatt
Do you have more than one mentor who should be listed for this submission?
ID: 32
No
Has your faculty or staff mentor reviewed your proposal and approved it for submission?
ID: 3
Yes: Yes
Presenters
ID: 4
| WOU Email | First Name | Last Name | vNumber | Major | Year (Senior, Junior, etc.) | Home Town |
|---|---|---|---|---|---|---|
| abanker20@mail.wou.edu | Ashley | Banker | V00376395 | Chemistry | Senior | Salem |
What type of session are you participating in?
ID: 6
Presentation
Do you have a session key provided by your faculty mentor(s)?
ID: 8
Yes
Session Key
ID: 9
WOU-aes2025
Select the sponsored section your presentation will be part of
ID: 10
Chemistry at the Forefront: Undergraduates Discussing Emerging Trends and Innovations
Title of your presentation/poster/performance
ID: 7
Unlocking the Puzzle of Anxiety: How Genes and Brain Patterns Shape Treatment Responses in Adolescents 11:30-12:00
Are there any accompanists or composers that should be recognized in the program?
ID: 14
No
Did your project involve Human Subjects?
ID: 15
No
Abstract or image files
ID: 17
I will add an abstract now
Abstract
ID: 21
Unlocking the Puzzle of Anxiety: How Genes and Brain Patterns Shape Treatment Responses in Adolescents
Generalized anxiety disorder (GAD) is a chronic condition marked by excessive worry and various somatic symptoms. Escitalopram, a selective serotonin reuptake inhibitor (SSRI), is often used as a first-line treatment, but its effectiveness varies, especially in adolescents. This study examined whether genetic and neurofunctional traits can predict how well an adolescent responds to escitalopram. Escitalopram targets the serotonin transporter (SERT), increasing serotonin levels by binding with high affinity to its orthosteric and allosteric sites. Researchers focused on CYP2C19, a gene affecting drug metabolism, and changes in amygdala-based functional connectivity (FC). They found escitalopram reduced anxiety more than placebo, with outcomes influenced by CYP2C19 metabolism rate and early FC changes. These findings suggest that genetic and brain imaging data could help personalize GAD treatment in adolescents.
Abstract Approved
Hidden
ID: 37
Yes
Do you give us permission to publish your work online in partnership with Hamersly Library?
ID: 16
Yes
Would you be interested in submitting your work to PURE Insights?
ID: 24
No
Model release statement
ID: 18
Yes
Are you willing to allow WOU to make a video recording of your session?
ID: 23
No
Name
Hidden
ID: 33
First: Ashley
Last: Banker
vNumber
Hidden
ID: 34
V00376395
Email
Hidden
ID: 35
abanker20@wou.edu
